Although there was no obvious improvement in glucose metabolism, doxazocin noticeably reduced insulin resistance.16 The effect of the α1‐adrenoceptor antagonist doxazocin on plasma insulin and blood glucose was studied on 10 newly diagnosed essential hypertension patients undergoing a glucose tolerance test. This evidence concerns the gene INS and essential hypertension.